Literature DB >> 25241891

Diagnostic performance of a novel cadmium-zinc-telluride gamma camera system assessed using fractional flow reserve.

Hirokazu Tanaka1, Taishiro Chikamori, Nobuhiro Tanaka, Satoshi Hida, Yuko Igarashi, Jun Yamashita, Masashi Ogawa, Chie Shiba, Yasuhiro Usui, Akira Yamashina.   

Abstract

BACKGROUND: Although the novel cadmium-zinc-telluride (CZT) camera system provides excellent image quality, its diagnostic value using thallium-201 as assessed on coronary angiography (CAG) and fractional flow reserve (FFR) has not been validated. METHODS AND 
RESULTS: To evaluate the diagnostic accuracy of the CZT ultrafast camera system (Discovery NM 530c), 95 patients underwent stress thallium-201 single-photon emission computed tomography (SPECT) and then CAG within 3 months. Image acquisition was performed in the supine and prone positions after stress for 5 and 3 min, respectively, and in the supine position at rest for 10 min. Significant stenosis was defined as ≥90% diameter narrowing on visual estimation, or a lesion with <90% and ≥50% stenosis and FFR ≤0.75. To detect individual coronary stenosis, the respective sensitivity, specificity, and accuracy were 90%, 64%, and 78% for left anterior descending coronary artery stenosis, 78%, 84%, and 81% for left circumflex stenosis, and 83%, 47%, and 60% for right coronary artery (RCA) stenosis. The combination of prone and supine imaging had a higher specificity for RCA disease than supine imaging alone (65% vs. 47%), with an improvement in accuracy from 60% to 72%.
CONCLUSIONS: Using thallium-201 with short acquisition time, combined with prone imaging, CZT SPECT had a high diagnostic yield in detecting significant coronary stenosis as assessed using FFR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25241891     DOI: 10.1253/circj.cj-14-0612

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Comparison of conventional and cadmium-zinc-telluride single-photon emission computed tomography for analysis of thallium-201 myocardial perfusion imaging: an exploratory study in normal databases for different ethnicities.

Authors:  Masaru Ishihara; Masahisa Onoguchi; Yasuyo Taniguchi; Takayuki Shibutani
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-29       Impact factor: 2.357

2.  Feasibility of data-driven cardiac respiratory motion correction of myocardial perfusion CZT SPECT: A pilot study.

Authors:  Doumit Daou; Rémy Sabbah; Carlos Coaguila; Hatem Boulahdour
Journal:  J Nucl Cardiol       Date:  2016-05-11       Impact factor: 5.952

3.  Diagnostic value of stress thallium-201/rest technetium-99m-sestamibi sequential dual isotope high-speed myocardial perfusion imaging for the detection of haemodynamically relevant coronary artery stenosis.

Authors:  Gilles Barone-Rochette; Feras Zoreka; Loïc Djaileb; Nicolas Piliero; Alex Calizzano; Jean Louis Quesada; Alexis Broisat; Laurent Riou; Jacques Machecourt; Daniel Fagret; Gerald Vanzetto; Catherine Ghezzi
Journal:  J Nucl Cardiol       Date:  2018-01-29       Impact factor: 5.952

4.  Feasibility of ultra low-dose thallium stress-redistribution protocol including prone imaging in obese patients using CZT camera.

Authors:  Vladimír Kincl; Milan Kamínek; Jiří Vašina; Roman Panovský; Martin Havel
Journal:  Int J Cardiovasc Imaging       Date:  2016-06-02       Impact factor: 2.357

Review 5.  Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database.

Authors:  Kenichi Nakajima; Naoya Matsumoto; Tokuo Kasai; Shinro Matsuo; Keisuke Kiso; Koichi Okuda
Journal:  Ann Nucl Med       Date:  2016-02-20       Impact factor: 2.668

6.  Comparison of CTAC and prone imaging for the detection of coronary artery disease using CZT SPECT.

Authors:  Shimpei Ito; Akihiro Endo; Taiji Okada; Taku Nakamura; Takashi Sugamori; Nobuyuki Takahashi; Hiroyuki Yoshitomi; Kazuaki Tanabe
Journal:  Ann Nucl Med       Date:  2017-07-10       Impact factor: 2.668

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.